US Stock MarketDetailed Quotes

KPRX Kiora Pharmaceuticals

Watchlist

4.6000
+0.1000+2.22%

Close Jul 22 16:00 ET

13.66MMarket Cap-390P/E (TTM)

Kiora Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

543.87%13.62M

8.35%-9.56M

-21.25%-2.58M

15.05%-2.52M

44.58%-1.38M

-8.37%-3.07M

2.32%-10.43M

27.08%-2.13M

-30.73%-2.97M

14.29%-2.5M

Net income from continuing operations

819.99%13.45M

7.88%-12.51M

9.20%-2.27M

-12.57%-5.76M

-8.87%-2.61M

47.59%-1.87M

1.36%-13.58M

59.59%-2.5M

-68.69%-5.12M

5.59%-2.4M

Operating gains losses

----

-101.79%-25.5K

----

610.76%1.42M

--0

--1.43M

--0

Depreciation and amortization

-51.69%4.87K

24.49%51.8K

-22.85%7.94K

10.11%11.31K

118.63%22.48K

-6.45%10.08K

-8.14%41.61K

-6.81%10.29K

-7.12%10.27K

-18.43%10.28K

Deferred tax

----

179.92%90.32K

----

41.32%-113.01K

----

Other non cash items

-100.35%-851

196.73%2M

190.93%39.01K

324.48%1.54M

157.43%177.84K

-15.19%241.7K

308.54%675.02K

-49.30%-42.9K

216.02%363.85K

-42.72%69.08K

Change In working capital

99.51%-7.81K

-372.54%-1.82M

-229.13%-606.84K

-317.46%-483.12K

444.44%856.78K

-805.65%-1.59M

164.54%668.51K

160.39%469.95K

-54.57%222.16K

49.28%-248.75K

-Change in receivables

96.74%-10.82K

37.20%-548.11K

-275.57%-529.11K

48.00%-575.17K

2,671.61%888.47K

-891.99%-332.29K

-97.81%-872.74K

384.05%301.37K

-883.60%-1.11M

78.80%-34.55K

-Change in prepaid assets

108.62%12.65K

-99.68%885

-46.51%-97.97K

-97.94%24.31K

143.01%221.38K

54.66%-146.84K

275.32%275.16K

74.76%-66.87K

1,090.63%1.18M

-148.30%-514.7K

-Change in payables and accrued expense

100.05%584

-191.06%-1.27M

-124.52%-58.68K

-48.53%87.39K

-164.71%-219.13K

-267.17%-1.08M

616.04%1.39M

166.49%239.35K

-69.01%169.78K

543.11%338.63K

-Change in other current assets

158.60%1.11K

66.25%-7.58K

65.99%-8.52K

-96.25%225

-96.19%284

103.96%430

-259.20%-22.47K

-2,050.27%-25.06K

258.22%5.99K

142.18%7.46K

-Change in other current liabilities

65.40%-11.34K

100.56%584

313.36%87.45K

29.31%-19.86K

24.92%-34.22K

35.86%-32.78K

43.05%-103.63K

143.65%21.16K

40.37%-28.1K

2.81%-45.58K

Cash from discontinued investing activities

Operating cash flow

543.87%13.62M

8.35%-9.56M

-21.25%-2.58M

15.05%-2.52M

44.58%-1.38M

-8.37%-3.07M

2.32%-10.43M

27.08%-2.13M

-30.73%-2.97M

14.29%-2.5M

Investing cash flow

Cash flow from continuing investing activities

104.06%6.38K

Net PPE purchase and sale

----

--0

----

109.98%6.38K

--0

Cash from discontinued investing activities

Investing cash flow

----

--0

----

104.06%6.38K

--0

Financing cash flow

Cash flow from continuing financing activities

2,871.23%15.25M

-30.80%5.97M

-115.00%-486.42K

5.94M

513.18K

-50.97%8.62M

1,627.78%3.24M

-44.88%5.38M

Net common stock issuance

6,332.43%13.81M

14.77%6.15M

-56.21%-813.32K

--0

--6.75M

--214.68K

-69.78%5.36M

---520.65K

-39.70%5.88M

--0

Proceeds from stock option exercised by employees

382.02%1.44M

-90.58%307.08K

-99.74%8.58K

--0

--298.5K

6,417.53%3.26M

--3.26M

--0

Net other financing activities

----

---495K

--318.32K

--0

----

Cash from discontinued financing activities

Financing cash flow

2,871.23%15.25M

-30.80%5.97M

-115.00%-486.42K

--0

--5.94M

--513.18K

-50.97%8.62M

1,627.78%3.24M

-44.88%5.38M

--0

Net cash flow

Beginning cash position

-59.11%2.46M

-23.87%6.01M

11.42%5.4M

221.16%7.96M

-32.90%3.43M

-23.87%6.01M

541.90%7.9M

-56.50%4.85M

-33.20%2.48M

-23.19%5.11M

Current changes in cash

1,229.41%28.87M

-99.40%-3.59M

-375.33%-3.07M

-204.61%-2.52M

282.25%4.55M

9.54%-2.56M

-126.68%-1.8M

134.55%1.11M

-67.81%2.41M

14.46%-2.5M

Effect of exchange rate changes

-87.97%-51.02K

142.36%36.02K

149.55%122.18K

17.26%-30.17K

78.82%-28.85K

-170.19%-27.15K

-4.34%-85.04K

280.45%48.96K

14.27%-36.47K

-424.71%-136.21K

End cash Position

811.90%31.28M

-59.11%2.46M

11.42%5.4M

221.16%7.96M

-32.90%3.43M

-23.87%6.01M

-56.50%4.85M

-33.20%2.48M

Free cash flow

543.87%13.62M

8.35%-9.56M

-21.25%-2.58M

15.05%-2.52M

44.58%-1.38M

-8.37%-3.07M

2.90%-10.43M

27.08%-2.13M

-30.73%-2.97M

14.46%-2.5M

Currency Unit

USD

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	543.87%13.62M	8.35%-9.56M	-21.25%-2.58M	15.05%-2.52M	44.58%-1.38M	-8.37%-3.07M	2.32%-10.43M	27.08%-2.13M	-30.73%-2.97M	14.29%-2.5M
Net income from continuing operations	819.99%13.45M	7.88%-12.51M	9.20%-2.27M	-12.57%-5.76M	-8.87%-2.61M	47.59%-1.87M	1.36%-13.58M	59.59%-2.5M	-68.69%-5.12M	5.59%-2.4M
Operating gains losses	----	-101.79%-25.5K	----	----	----	----	610.76%1.42M	--0	--1.43M	--0
Depreciation and amortization	-51.69%4.87K	24.49%51.8K	-22.85%7.94K	10.11%11.31K	118.63%22.48K	-6.45%10.08K	-8.14%41.61K	-6.81%10.29K	-7.12%10.27K	-18.43%10.28K
Deferred tax	----	179.92%90.32K	----	----	----	----	41.32%-113.01K	----	----	----
Other non cash items	-100.35%-851	196.73%2M	190.93%39.01K	324.48%1.54M	157.43%177.84K	-15.19%241.7K	308.54%675.02K	-49.30%-42.9K	216.02%363.85K	-42.72%69.08K
Change In working capital	99.51%-7.81K	-372.54%-1.82M	-229.13%-606.84K	-317.46%-483.12K	444.44%856.78K	-805.65%-1.59M	164.54%668.51K	160.39%469.95K	-54.57%222.16K	49.28%-248.75K
-Change in receivables	96.74%-10.82K	37.20%-548.11K	-275.57%-529.11K	48.00%-575.17K	2,671.61%888.47K	-891.99%-332.29K	-97.81%-872.74K	384.05%301.37K	-883.60%-1.11M	78.80%-34.55K
-Change in prepaid assets	108.62%12.65K	-99.68%885	-46.51%-97.97K	-97.94%24.31K	143.01%221.38K	54.66%-146.84K	275.32%275.16K	74.76%-66.87K	1,090.63%1.18M	-148.30%-514.7K
-Change in payables and accrued expense	100.05%584	-191.06%-1.27M	-124.52%-58.68K	-48.53%87.39K	-164.71%-219.13K	-267.17%-1.08M	616.04%1.39M	166.49%239.35K	-69.01%169.78K	543.11%338.63K
-Change in other current assets	158.60%1.11K	66.25%-7.58K	65.99%-8.52K	-96.25%225	-96.19%284	103.96%430	-259.20%-22.47K	-2,050.27%-25.06K	258.22%5.99K	142.18%7.46K
-Change in other current liabilities	65.40%-11.34K	100.56%584	313.36%87.45K	29.31%-19.86K	24.92%-34.22K	35.86%-32.78K	43.05%-103.63K	143.65%21.16K	40.37%-28.1K	2.81%-45.58K
Cash from discontinued investing activities
Operating cash flow	543.87%13.62M	8.35%-9.56M	-21.25%-2.58M	15.05%-2.52M	44.58%-1.38M	-8.37%-3.07M	2.32%-10.43M	27.08%-2.13M	-30.73%-2.97M	14.29%-2.5M
Investing cash flow
Cash flow from continuing investing activities		0	0	0			104.06%6.38K	0	0	0
Net PPE purchase and sale	----	--0	--0	--0	----	----	109.98%6.38K	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	----	--0	--0	--0	----	----	104.06%6.38K	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	2,871.23%15.25M	-30.80%5.97M	-115.00%-486.42K	0	5.94M	513.18K	-50.97%8.62M	1,627.78%3.24M	-44.88%5.38M	0
Net common stock issuance	6,332.43%13.81M	14.77%6.15M	-56.21%-813.32K	--0	--6.75M	--214.68K	-69.78%5.36M	---520.65K	-39.70%5.88M	--0
Proceeds from stock option exercised by employees	382.02%1.44M	-90.58%307.08K	-99.74%8.58K	--0	--0	--298.5K	6,417.53%3.26M	--3.26M	--0	--0
Net other financing activities	----	---495K	--318.32K	--0	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	2,871.23%15.25M	-30.80%5.97M	-115.00%-486.42K	--0	--5.94M	--513.18K	-50.97%8.62M	1,627.78%3.24M	-44.88%5.38M	--0
Net cash flow
Beginning cash position	-59.11%2.46M	-23.87%6.01M	11.42%5.4M	221.16%7.96M	-32.90%3.43M	-23.87%6.01M	541.90%7.9M	-56.50%4.85M	-33.20%2.48M	-23.19%5.11M
Current changes in cash	1,229.41%28.87M	-99.40%-3.59M	-375.33%-3.07M	-204.61%-2.52M	282.25%4.55M	9.54%-2.56M	-126.68%-1.8M	134.55%1.11M	-67.81%2.41M	14.46%-2.5M
Effect of exchange rate changes	-87.97%-51.02K	142.36%36.02K	149.55%122.18K	17.26%-30.17K	78.82%-28.85K	-170.19%-27.15K	-4.34%-85.04K	280.45%48.96K	14.27%-36.47K	-424.71%-136.21K
End cash Position	811.90%31.28M	-59.11%2.46M	-59.11%2.46M	11.42%5.4M	221.16%7.96M	-32.90%3.43M	-23.87%6.01M	-23.87%6.01M	-56.50%4.85M	-33.20%2.48M
Free cash flow	543.87%13.62M	8.35%-9.56M	-21.25%-2.58M	15.05%-2.52M	44.58%-1.38M	-8.37%-3.07M	2.90%-10.43M	27.08%-2.13M	-30.73%-2.97M	14.46%-2.5M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall